SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000921895-21-000060
Filing Date
2021-01-08
Accepted
2021-01-08 09:07:43
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 forms312566003_01052021.htm S-3 180196
2 EX-5.1 ex51tos312566003_01052021.htm EX-5.1 10006
3 EX-23.1 ex231tos312566003_01052021.htm EX-23.1 3441
4 GRAPHIC image_001.gif GRAPHIC 4449
5 GRAPHIC image_001.jpg GRAPHIC 3560
  Complete submission text file 0000921895-21-000060.txt   206114
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-251958 | Film No.: 21515839
SIC: 2834 Pharmaceutical Preparations